---
title: "Capsaicin Cream 0.025%, External Analgesic Cream, Penetrating Pain Relief, NE... — FDA record D-1147-2023 | Is It on Recall"
description: "Product mix-up: Cartons labeled Capsaicin Cream 0.025% may contain tubes of Sodium Fluoride 1.1% Prescription Dental Toothpaste"
url: https://isitonrecall.com/recall/fda-drug-d-1147-2023-capsaicin-cream-0-025-external-analgesic-cream-penetrating-pain-relief-net-wt-2-1-oz-60g-ndc-50268-1/
updated: 2026-10-01
site: "Is It on Recall"
language: en
---

[Recall archive](https://isitonrecall.com/archives/) / FDA drug enforcement

# Capsaicin Cream 0.025%, External Analgesic Cream, Penetrating Pain Relief, NET WT. 2.1 OZ. (60g) NDC 50268-195-60, Ma... — FDA record D-1147-2023

Reported terminated

Status as reported in the agency record. FDA warns that enforcement status may not track the current recall lifecycle; check the current official notice.

Source date Aug 11, 2023. Retrieved Oct 1, 2026. Last updated Oct 1, 2026.

Archive changed Oct 1, 2026. USDA FSIS records are unavailable; [check FSIS directly](https://www.fsis.usda.gov/recalls). [Source coverage and dates](https://isitonrecall.com/sources/).

## What the record says

- **Product**: Capsaicin Cream 0.025%, External Analgesic Cream, Penetrating Pain Relief, NET WT. 2.1 OZ. (60g) NDC 50268-195-60, Manufactured for: AvKARE, Pulaski, TN 38478
- **Reason**: Product mix-up: Cartons labeled Capsaicin Cream 0.025% may contain tubes of Sodium Fluoride 1.1% Prescription Dental Toothpaste
- **Classification**: Class II
- **Recalling firm**: AVKARE LLC
- **Quantity**: 35,184 cartons
- **Agency-reported status**: Terminated
- **Source record identifier**: D-1147-2023

[Open the official record](https://api.fda.gov/drug/enforcement.json?search=recall_number%3A%22D-1147-2023%22)

[What the recall classes mean](https://isitonrecall.com/guides/recall-classes/). Classification is an agency assessment, not individual medical advice.

## Lot and product identifiers

| Label field | Details supplied by the agency |
| --- | --- |
| Lot, code or applicability | Lot # P22078; Exp. 11/30/2024 |

Match all identifying details in the current notice. A brand name alone is not enough.

## Distribution

Affected product was distributed to nineteen (19) consignees within the united states.

No US distribution state could be established from this record. Check the official notice.

## Dates in the source

- **Report date**: Sep 13, 2023
- **Recall initiation date**: Aug 11, 2023
- **Center classification date**: Sep 7, 2023
- **Termination date**: Apr 29, 2024

FDA company pages use the listing date; enforcement records use initiation dates; CPSC uses recall date; NHTSA uses report-received date. These dates are not interchangeable.

## What to do next

Read the official notice for the action that applies to your exact product.

[Read the current instructions](https://api.fda.gov/drug/enforcement.json?search=recall_number%3A%22D-1147-2023%22)

## Before changing a medicine

Follow urgent instructions in the current official recall notice. Speak to your pharmacist or prescriber before stopping or changing a prescribed medicine.

Talk to your doctor or pharmacist if you have questions or concerns about your medicine. [FDA medication recall guidance](https://www.fda.gov/drugs/drug-recalls/understanding-drug-recalls-what-know-and-what-do)

## Related records

[Medications records](https://isitonrecall.com/category/medications/) [AVKARE LLC records](https://isitonrecall.com/brand/avkare-llc/)